Skip to main content
. 2017 Jul 14;11(1):69–82. doi: 10.1007/s40271-017-0266-4

Table 1.

ALGS population: patient demographic and clinical characteristics reported by caregivers (for patients under 18 years of age) or patients

Demographic and clinical characteristics N = 25
Sex, n (%)
 Male 10 (40.0)
 Female 15 (60.0)
Age, years
 Mean 8.3
 Median 5.8
 Range 0.44–34.9
Race/ethnicitya, n (%)
 Asian 1 (4.0)
 Black/African–American 5 (20.0)
 Hispanic/Spanish American/Latino (of any race) 4 (16.0)
 White/Caucasian 14 (56.0)
Severity of reported itching, n (%)
 Very mild 7 (28.0)
 Mild 7 (28.0)
 Moderate 7 (28.0)
 Severe 4 (16.0)
Patient receiving treatment for any aspect of ALGS, n (%)
 Yes 20 (80.0)
 No 2 (8.0)
 Not answered 3 (12.0)
Patient has undergone surgery for any aspect of ALGSb, n (%)
 Yes 9 (36.0)
 No 14 (56.0)
 Not answered 2 (8.0)
Type of surgery for ALGS, n (%)
 Biliary diversionc 3 (12.0)
 Open biopsy and catheterization 1 (4.0)
 Tetralogy of Fallot repair 1 (4.0)
 Liver biopsy 1 (4.0)
 Liver transplant 1 (4.0)
 Bone graft/hardware 1 (4.0)
 Not answeredd 17 (68.0)
Patient receiving treatment for itching, n (%)
 Yes 18 (72.0)
 No 4 (16.0)
 Not answered 3 (12.0)
Current itching treatmentse, n (%)
 Rifampin 12 (48.0)
 Hydroxyzine (Atarax) 10 (40.0)
 Ursodeoxycholic acid 6 (24.0)
 Naltrexone 3 (12.0)
 Clonidine 1 (4.0)
 Unspecified medications 3 (12.0)

ALGS Alagille syndrome

aRace information was not provided for one participant

bWhile any surgical interruption of the enterohepatic circulation and liver transplant were exclusion criteria for this study, all patients who had undergone these surgery types continued to experience itching following surgery and were, therefore, included in the study

cIncluding partial external biliary diversion, ileal exclusion, biliary diversion and partial internal biliary diversion

dIncludes one patient for whom surgery type was not specified

eMore than one treatment was reported for some participants